Prada Group to Acquire Versace From Capri Holdings

Tapestry Acquires Capri Holdings for $8.5 Billion

August 10, 2023

Consumer Products

Tapestry, Inc. entered into a definitive agreement to acquire Capri Holdings Limited in an all-cash transaction valued at approximately $8.5 billion. Under the terms of the deal, Capri Holdings shareholders will receive $57.00 per share in cash, with the transaction expected to close in calendar year 2024 subject to shareholder and regulatory approvals.

Capri Holdings Acquires Tuscan Shoemaker Sicla

March 23, 2024

Manufacturing

Capri Holdings has signed an agreement to acquire Sicla, a Montevarchi-based Italian shoemaker known for producing part of Jimmy Choo's collections. The Donnini family will continue to oversee operations; financial terms were not disclosed. The acquisition strengthens Capri's production capabilities and secures a supplier in Tuscany's luxury footwear cluster.

VF Corporation Acquires Supreme

November 9, 2020

Consumer Products

VF Corporation has signed a definitive agreement to acquire the privately owned streetwear brand Supreme in an all-cash deal valuing the brand at about $2.1 billion. Current investors The Carlyle Group and Goode Partners are selling their stakes; Supreme's founder James Jebbia and senior leadership will remain with the company, headquartered in New York City.

MondeVita (Mondevo Group) Acquires Raffaele Caruso S.p.A. from Lanvin Group

February 6, 2026

Consumer Products

MondeVita, the lifestyle and luxury division of Mondevo Group, completed the acquisition of Raffaele Caruso S.p.A. (Caruso) from Lanvin Group in a strategic carve-out announced Feb. 6, 2026. Caruso, a high-end Italian menswear manufacturer headquartered in Soragna (Parma) with more than 450 employees and roughly €35 million in annual revenue, will serve as the cornerstone of MondeVita's luxury platform; ITTIKAR (Mondevo's AI-native merchant bank) served as exclusive advisor.

Merck to Acquire Verona Pharma for Approximately $10 Billion

July 9, 2025

Pharmaceuticals

Merck, through a subsidiary, entered into a definitive agreement to acquire Verona Pharma in a transaction valued at approximately $10 billion (at $107 per ADS). The acquisition is intended to add Ohtuvayre (ensifentrine) to Merck’s cardio-pulmonary pipeline, following FDA approval for COPD in June 2024.

L'OCCITANE Group Acquires Dr. Vranjes Firenze

January 4, 2024

Consumer Products

The L'OCCITANE Group has agreed to acquire Italian luxury home fragrance brand Dr. Vranjes Firenze, expanding its portfolio of premium beauty and fragrance brands. The deal, expected to complete by the end of Q1 2024, brings Dr. Vranjes' in‑house production, R&D and retail footprint (28 mono-brand stores and 650 points of sale across ~75 countries) into L'OCCITANE's global platform.